BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24598726)

  • 1. Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.
    Tongo M; Zembe L; Ebong E; Roux S; Bekker LG; Williamson C; Mpoudi-Ngole E; Burgers WA
    Vaccine; 2014 Apr; 32(20):2328-36. PubMed ID: 24598726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.
    Côrtes FH; Bello G; Vorsatz C; Pilotto JH; Guimarães ML; Grinsztejn B; Veloso VG; Pinto AR; Morgado MG
    Vaccine; 2013 Feb; 31(7):1106-12. PubMed ID: 23261042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.
    Serwanga J; Mugaba S; Pimego E; Nanteza B; Lyagoba F; Nakubulwa S; Heath L; Nsubuga RN; Ndembi N; Gotch F; Kaleebu P
    AIDS Res Hum Retroviruses; 2012 Apr; 28(4):384-92. PubMed ID: 21867408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa).
    Inwoley A; Recordon-Pinson P; Dupuis M; Gaston J; Genête M; Minga A; Letourneur F; Rouet F; Choppin J; Fleury H; Guillet JG; Andrieu M;
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):620-8. PubMed ID: 16060833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
    Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials.
    Zembe L; Burgers WA; Jaspan HB; Bekker LG; Bredell H; Stevens G; Gilmour J; Cox JH; Fast P; Hayes P; Vardas E; Williamson C; Gray CM
    PLoS One; 2011; 6(10):e26096. PubMed ID: 22022524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
    Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
    AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon.
    Tongo M; Riou C; Crunchant E; Müller TL; Strickland N; Mpoudi-Ngole E; Burgers WA
    AIDS; 2015 Mar; 29(5):635-639. PubMed ID: 25715106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic.
    Tongo M; Martin DP; Zembe L; Mpoudi-Ngole E; Williamson C; Burgers WA
    Virol J; 2013 Jan; 10():29. PubMed ID: 23339631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
    Geels MJ; Dubey SA; Anderson K; Baan E; Bakker M; Pollakis G; Paxton WA; Shiver JW; Goudsmit J
    J Virol; 2005 Sep; 79(17):11247-58. PubMed ID: 16103177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance.
    Yang OO; Ali A; Kasahara N; Faure-Kumar E; Bae JY; Picker LJ; Park H
    J Virol; 2015 Jan; 89(2):1195-204. PubMed ID: 25378501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d'Ivoire.
    Chahroudi A; Sawadogo S; Ellenberger D; Pieniazek D; Borget-Alloue MY; Aidoo M; Koblavi-Deme S; Fernandez-Vina M; Maurice C; Chorba T; Nkengasong JN; McNicholl JM
    J Infect Dis; 2005 Oct; 192(8):1417-21. PubMed ID: 16170760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa.
    Vidal N; Diop H; Montavon C; Butel C; Bosch S; Ngole EM; Touré-Kane C; Mboup S; Delaporte E; Peeters M
    Infect Genet Evol; 2013 Mar; 14():73-82. PubMed ID: 23232100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.
    Mendiratta S; Vajpayee M; Malhotra U; Kaushik S; Dar L; Mojumdar K; Chauhan NK; Sreenivas V
    Med Microbiol Immunol; 2009 Feb; 198(1):47-56. PubMed ID: 18985383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.
    Kaufmann DE; Bailey PM; Sidney J; Wagner B; Norris PJ; Johnston MN; Cosimi LA; Addo MM; Lichterfeld M; Altfeld M; Frahm N; Brander C; Sette A; Walker BD; Rosenberg ES
    J Virol; 2004 May; 78(9):4463-77. PubMed ID: 15078927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity.
    Frahm N; Nickle DC; Linde CH; Cohen DE; Zuñiga R; Lucchetti A; Roach T; Walker BD; Allen TM; Korber BT; Mullins JI; Brander C
    AIDS; 2008 Feb; 22(4):447-56. PubMed ID: 18301057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.
    Radebe M; Gounder K; Mokgoro M; Ndhlovu ZM; Mncube Z; Mkhize L; van der Stok M; Jaggernath M; Walker BD; Ndung'u T
    AIDS; 2015 Jan; 29(1):23-33. PubMed ID: 25387316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.
    Coplan PM; Gupta SB; Dubey SA; Pitisuttithum P; Nikas A; Mbewe B; Vardas E; Schechter M; Kallas EG; Freed DC; Fu TM; Mast CT; Puthavathana P; Kublin J; Brown Collins K; Chisi J; Pendame R; Thaler SJ; Gray G; Mcintyre J; Straus WL; Condra JH; Mehrotra DV; Guess HA; Emini EA; Shiver JW
    J Infect Dis; 2005 May; 191(9):1427-34. PubMed ID: 15809900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.